Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,592 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06662006RecruitingPhase 2
Nal-IRI chemo with immunotherapy and radiation for pancreatic cancer
This trial tests a combination of chemotherapy (Nal-IRI, 5-FU, leucovorin), an immunotherapy drug (PD-L1 inhibitor), and a targeted anti-angiogenic pill, with or without radiation (SBRT), as a second-line treatment for people with metastatic pancreatic cancer that has progressed after first-line therapy.
Nanjing, JiangsuAges 18–75 - NCT06664021RecruitingPhase 2
Tislelizumab and S-1 for recurrent high-risk bile duct cancer
This trial tests a combination of two drugs (tislelizumab and S-1) for people whose bile duct cancer has come back after surgery and had high-risk features. The goal is to see if this treatment can help control the cancer.
Fuyang, AnhuiAges 18–75 - NCT06676774RecruitingPhase 2
Does oxytocin nasal spray help people with diabetes insipidus?
This study tests if a nasal spray with oxytocin (a natural hormone) can improve emotion recognition and reduce stress-related hormone levels in people with central diabetes insipidus compared to healthy volunteers.
BaselAges 18 years+ - NCT06690593Recruiting
Gut Microbiome Study for Healthy Adults Age 45+
This study compares the gut bacteria of healthy adults (age 45+) with those who have a blood condition called monoclonal gammopathy. The goal is to see if gut bacteria patterns differ between the two groups.
Guanzhou, GuangdongAges 45 years+ - NCT07586735Recruiting
A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Beijing, Beijing MunicipalityAges 40–60 - NCT06714123RecruitingPhase 2
Senicapoc for worsening lung scarring
This trial tests if the drug senicapoc can help people whose lung scarring (pulmonary fibrosis) is getting worse despite standard care. It aims to slow down the decline in lung function.
Aarhus NAges 18 years+ - NCT06740916RecruitingPhase 3
Aspirin once vs. twice daily for high-risk MPN patients
This trial tests whether taking aspirin once or twice daily better prevents blood clots in high-risk patients with myeloproliferative neoplasms (MPNs) who don't respond fully to aspirin. It's for people whose blood tests show aspirin resistance.
Bangkok Noi, BangkokAges 18 years+ - NCT06749886RecruitingPhase 2
Tislelizumab plus chemo for advanced lung cancer after prior immunotherapy
This trial tests a drug called Tislelizumab (an immunotherapy) combined with chemotherapy for people with advanced NSCLC who have already been helped by a different immunotherapy. It's a second-line option for those who did well on their first immunotherapy but now need another treatment.
ShanghaiAges 18 years+ - NCT06771791RecruitingPhase 3
Apple oral immunotherapy trial for birch pollen and apple allergy
This trial tests if eating small amounts of raw apple can help people with birch pollen allergy who also have mouth itching or swelling from apples. You will be given gradually increasing doses of apple to see if your allergy improves.
Strasbourg, FranceAges 18 years+ - NCT06778317Recruiting
Blood test to predict liver cancer in cirrhosis patients
This trial tests if a simple blood test can help predict who with cirrhosis might develop liver cancer, so doctors can monitor and treat those patients earlier.
Vandœuvre-lès-NancyAges 18 years+ - NCT06793449RecruitingPhase 2
BCMA CAR-T vs. stem cell transplant for multiple myeloma
This trial tests whether a newer immune treatment (BCMA CAR-T) works better than a stem cell transplant for people with multiple myeloma who are able to have a transplant. Both treatments aim to kill myeloma cells, but CAR-T uses your own engineered immune cells.
TianjinAges 18–70 - NCT06802055RecruitingPhase 2
Sirolimus with or without cyclosporin for aplastic anemia
This trial tests if sirolimus (an immune-suppressing drug) works better than current treatments for aplastic anemia patients who did not improve or had side effects from cyclosporin. It aims to find a new option to help your body make more blood cells.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06821217Recruiting
App-based support for endometriosis quality of life
This trial tests whether using a smartphone app can improve quality of life for people with endometriosis. You'll use the app to track symptoms and get support, and researchers will see if it helps you feel better.
BernAges 18 years+ - NCT06829732Recruiting
Closed-loop oxygen control for ICU patients on a breathing machine
This trial tests a closed-loop system that automatically adjusts the oxygen level in your breathing tube, aiming to keep your oxygen levels in a safe range with less need for manual changes. It may help if you are in the ICU, need a breathing machine, and have low blood oxygen despite receiving extra oxygen.
Sabadell, BarcelonaAges 18 years+ - NCT06843889RecruitingPhase 2
Toripalimab with chemoradiation before surgery for esophageal cancer
This trial tests whether adding the immunotherapy drug toripalimab to standard chemoradiation before surgery helps people with a type of esophageal cancer. It is for patients whose cancer has not spread to other organs and who have not had treatment before.
Guangzhou, Baiyun DistrictAges 18–75 - NCT06853535RecruitingPhase 3
Personalized antiplatelet therapy after stroke or TIA
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Chengdu, SichuanAges 18 years+ - NCT06889948RecruitingPhase 2
Daratumumab for kidney disease caused by abnormal proteins
This trial tests if daratumumab can help people with a kidney condition called MGRS, where abnormal proteins damage the kidneys. The goal is to see if the drug can reduce protein in the urine and protect kidney function.
HelsinkiAges 18 years+ - NCT06922370Recruiting
Study of bone and joint problems in Gitelman syndrome
This study looks at bone and joint problems in people with Gitelman syndrome, a rare kidney disorder. It aims to understand how this condition affects the body's bones and joints.
Hangzhou, ZhejiangAges Any age - NCT06928649Recruiting
Studying cell damage in critically ill ICU patients
This trial looks at specific cell damage processes (called ferroptosis and pyroptosis) in very sick ICU patients. The goal is to learn more about these processes so doctors can better treat life-threatening organ failure caused by conditions like sepsis, trauma, or severe bleeding.
EdegemAges 18 years+ - NCT06989125Recruiting
Online vs. video therapy for gambling disorder
This trial compares two types of cognitive behavioral therapy for gambling disorder: one you do online on your own schedule and one face-to-face with a therapist over video. The goal is to see which works better, so you can choose the option that fits your life.
Aarhus, DenmarkAges 18 years+ - NCT06999785Recruiting
Oxygen therapy safety study for radiation treatment side effects
This trial tests whether extra oxygen sessions (hyperbaric oxygen therapy) cause DNA damage in people who have had radiation for cancer. It looks at patients with side effects like bladder or skin issues from past radiation.
AngersAges 18 years+ - NCT07021170RecruitingPhase 4
Study comparing special vs. standard vitamins after weight-loss surgery
This study tests whether a special brand of bariatric vitamins works better than standard multivitamins for people who have had weight-loss surgery. It aims to find the best way to prevent vitamin deficiencies after surgery.
Alexandria, Alexandria GovernorateAges 18–65 - NCT07042139Recruiting
No reduction vs. closed reduction for wrist fractures in older adults
This trial compares two approaches for treating a broken wrist (distal radius fracture) in people 65 and older: no reduction (letting the bone heal without realigning it) versus closed reduction (realigning the bone without surgery). It aims to see if skipping reduction leads to similar outcomes and avoids unnecessary procedures.
ViborgAges 65 years+ - NCT07043335Recruiting
Mesotherapy vs. shock wave for tennis elbow pain
This trial compares two treatments for tennis elbow: mesotherapy (injections into the skin) and shock wave therapy (sound waves). It aims to find which works better for pain that has lasted at least 6 weeks.
IstanbulAges 18–65
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,592 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.